Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19
Hospitalized patients with COVID-19 who have not previously received DOAK by it is not advisable to prescribe POAC for the prevention of thrombosis in patients with COVID-19 due to the lack of clinical trial results, significant potential interactions.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Izdatelstvo OKI
2020-10-01
|
| Series: | Качественная клиническая практика |
| Subjects: | |
| Online Access: | https://www.clinvest.ru/jour/article/view/519 |
| _version_ | 1797262067476987904 |
|---|---|
| author | V. A. Otdelenov K. B. Mirzaev D. A. Sychev |
| author_facet | V. A. Otdelenov K. B. Mirzaev D. A. Sychev |
| author_sort | V. A. Otdelenov |
| collection | DOAJ |
| description | Hospitalized patients with COVID-19 who have not previously received DOAK by it is not advisable to prescribe POAC for the prevention of thrombosis in patients with COVID-19 due to the lack of clinical trial results, significant potential interactions. |
| first_indexed | 2024-04-24T23:51:13Z |
| format | Article |
| id | doaj.art-c642c348f7d74c5f821007ddf6ae9220 |
| institution | Directory Open Access Journal |
| issn | 2588-0519 2618-8473 |
| language | Russian |
| last_indexed | 2024-04-24T23:51:13Z |
| publishDate | 2020-10-01 |
| publisher | Izdatelstvo OKI |
| record_format | Article |
| series | Качественная клиническая практика |
| spelling | doaj.art-c642c348f7d74c5f821007ddf6ae92202024-03-14T18:09:08ZrusIzdatelstvo OKIКачественная клиническая практика2588-05192618-84732020-10-0104S182210.37489/2588-0519-2020-S4-18-22503Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19V. A. Otdelenov0K. B. Mirzaev1D. A. Sychev2ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииHospitalized patients with COVID-19 who have not previously received DOAK by it is not advisable to prescribe POAC for the prevention of thrombosis in patients with COVID-19 due to the lack of clinical trial results, significant potential interactions.https://www.clinvest.ru/jour/article/view/519коронавируспрямые пероральные антикоагулянтыcovid-19 |
| spellingShingle | V. A. Otdelenov K. B. Mirzaev D. A. Sychev Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 Качественная клиническая практика коронавирус прямые пероральные антикоагулянты covid-19 |
| title | Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 |
| title_full | Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 |
| title_fullStr | Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 |
| title_full_unstemmed | Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 |
| title_short | Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 |
| title_sort | possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with covid 19 |
| topic | коронавирус прямые пероральные антикоагулянты covid-19 |
| url | https://www.clinvest.ru/jour/article/view/519 |
| work_keys_str_mv | AT vaotdelenov possibilitytousedirectoralanticoagulantstopreventthromboemboliceventsinpatientswithcovid19 AT kbmirzaev possibilitytousedirectoralanticoagulantstopreventthromboemboliceventsinpatientswithcovid19 AT dasychev possibilitytousedirectoralanticoagulantstopreventthromboemboliceventsinpatientswithcovid19 |